Colorimetric and Electrochemical Dual-Mode Detection of Thioredoxin 1 Based on the Efficient Peroxidase-Mimicking and Electrocatalytic Property of Prussian Blue Nanoparticles
-
Published:2024-04-10
Issue:4
Volume:14
Page:185
-
ISSN:2079-6374
-
Container-title:Biosensors
-
language:en
-
Short-container-title:Biosensors
Author:
Kim Jeong Un1, Kim Jee Min1, Thamilselvan Annadurai1ORCID, Nam Ki-Hwan2ORCID, Kim Moon Il1ORCID
Affiliation:
1. Department of BioNano Technology, Gachon University, 1342 Seongnamdae-ro, Sujeong-gu, Seongnam 13120, Republic of Korea 2. Division of Research and Development Equipment Industry, Center for Scientific Instrumentation, Korea Basic Science Institute, 169-148 Gwahak-ro, Yuseong-gu, Daejeon 34133, Republic of Korea
Abstract
As a potent detection method for cancer biomarkers in physiological fluid, a colorimetric and electrochemical dual-mode sensing platform for breast cancer biomarker thioredoxin 1 (TRX1) was developed based on the excellent peroxidase-mimicking and electrocatalytic property of Prussian blue nanoparticles (PBNPs). PBNPs were hydrothermally synthesized using K3[Fe(CN)6] as a precursor and polyvinylpyrrolidone (PVP) as a capping agent. The synthesized spherical PBNPs showed a significant peroxidase-like activity, having approximately 20 and 60% lower Km values for 3,3′,5,5′-tetramethylbenzidine (TMB) and H2O2, respectively, compared to those of horseradish peroxidase (HRP). The PBNPs also enhanced the electron transfer on the electrode surface. Based on the beneficial features, PBNPs were used to detect target TRX1 via sandwich-type immunoassay procedures. Using the strategies, TRX1 was selectively and sensitively detected, yielding limit of detection (LOD) values as low as 9.0 and 6.5 ng mL−1 via colorimetric and electrochemical approaches, respectively, with a linear range of 10–50 ng mL−1 in both strategies. The PBNP-based TRX1 immunoassays also exhibited a high degree of precision when applied to real human serum samples, demonstrating significant potentials to replace conventional HRP-based immunoassay systems into rapid, robust, reliable, and convenient dual-mode assay systems which can be widely utilized for the identification of important target molecules including cancer biomarkers.
Funder
National Research Foundation of Korea Korea Basic Science Institute
Reference53 articles.
1. Cancer statistics, 2023;Siegel;CA Cancer J. Clin.,2023 2. Li, J., Guan, X., Fan, Z., Ching, L.-M., Li, Y., Wang, X., Cao, W.-M., and Liu, D.-X. (2020). Non-invasive biomarkers for early detection of breast cancer. Cancers, 12. 3. Panagopoulou, M., Esteller, M., and Chatzaki, E. (2021). Circulating cell-free dna in breast cancer: Searching for hidden information towards precision medicine. Cancers, 13. 4. Wu, H.-J., and Chu, P.-Y. (2022). Current and developing liquid biopsy techniques for breast cancer. Cancers, 14. 5. Exosomes in cancer liquid biopsy: A focus on breast cancer;Halvaei;Mol. Ther. Nucleic Acids,2018
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|